MedPath

Motric Bio

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

Study of the Oral Treatment MTR-601 in Cervical Dystonia

Phase 2
Recruiting
Conditions
Cervical Dystonia
Interventions
Drug: Placebo
First Posted Date
2025-02-17
Last Posted Date
2025-07-09
Lead Sponsor
Motric Bio
Target Recruit Count
80
Registration Number
NCT06830642
Locations
🇺🇸

University of South Florida, Tampa, Florida, United States

🇺🇸

Michigan State University, Department of Neurology, East Lansing, Michigan, United States

🇺🇸

University of New Mexico, The Nene and Jamie Koch Comprehensive Movement Disorder Clinic, Albuquerque, New Mexico, United States

and more 10 locations

Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals

Phase 1
Completed
Conditions
Multiple Sclerosis
Spinal Cord Injuries
Cerebral Palsy
Stroke
Dystonia
Hypertonia, Muscle
Muscle Spasticity
Hereditary Spastic Paraplegia
Interventions
First Posted Date
2023-11-03
Last Posted Date
2025-03-12
Lead Sponsor
Motric Bio
Target Recruit Count
89
Registration Number
NCT06117020
Locations
🇺🇸

Worldwide Clinical Trials, San Antonio, Texas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.